APIE Therapeutics | WRAL TechWire

APIE Therapeutics

Triangle biotech startup aims to slow disease progression with RTI compounds

APIE, based in Research Triangle Park, is now raising a Series A round of funding. The company has hired an investment banker and recently scored a win by adding life sciences industry heavyweight Jim Greenwood to its board. Greenwood is known in biopharma for his 18-year tenure as president and CEO of BIO, the world’s largest biotech industry organization.

Read More